Iring Heisler

1.5k total citations
22 papers, 1.2k citations indexed

About

Iring Heisler is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Iring Heisler has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Iring Heisler's work include Toxin Mechanisms and Immunotoxins (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (4 papers). Iring Heisler is often cited by papers focused on Toxin Mechanisms and Immunotoxins (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (4 papers). Iring Heisler collaborates with scholars based in Germany, United States and Denmark. Iring Heisler's co-authors include Hendrik Fuchs, Mark Sutherland, Hölger Siebeneicher, Hartmut Rehwinkel, Roland Neuhaus, Marcus Bauser, Thomas Müller, Bernd Buchmann, R Tauber and Christopher Bachran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Iring Heisler

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iring Heisler Germany 14 707 368 255 242 122 22 1.2k
Claudia R. Oliva United States 27 1.2k 1.6× 542 1.5× 159 0.6× 288 1.2× 143 1.2× 44 2.0k
Jessica Hauschild Germany 17 565 0.8× 186 0.5× 284 1.1× 185 0.8× 233 1.9× 34 1.1k
Feifei Xu China 24 1.2k 1.6× 352 1.0× 395 1.5× 362 1.5× 51 0.4× 76 1.8k
Melissa Millard United States 14 1.1k 1.6× 228 0.6× 151 0.6× 298 1.2× 132 1.1× 18 1.9k
Danuta Duś Poland 23 776 1.1× 171 0.5× 327 1.3× 378 1.6× 56 0.5× 106 1.5k
Craig D. Simpson Canada 16 901 1.3× 382 1.0× 168 0.7× 381 1.6× 41 0.3× 25 1.5k
Helena Pópulo Portugal 13 1.2k 1.7× 344 0.9× 250 1.0× 518 2.1× 62 0.5× 21 1.9k
Kazi Mokim Ahmed United States 21 988 1.4× 422 1.1× 212 0.8× 504 2.1× 27 0.2× 32 1.6k
Rama Rao Malla India 17 758 1.1× 454 1.2× 216 0.8× 341 1.4× 37 0.3× 43 1.3k
Valeriy Filonenko Ukraine 26 1.7k 2.4× 148 0.4× 244 1.0× 273 1.1× 45 0.4× 143 2.1k

Countries citing papers authored by Iring Heisler

Since Specialization
Citations

This map shows the geographic impact of Iring Heisler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iring Heisler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iring Heisler more than expected).

Fields of papers citing papers by Iring Heisler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iring Heisler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iring Heisler. The network helps show where Iring Heisler may publish in the future.

Co-authorship network of co-authors of Iring Heisler

This figure shows the co-authorship network connecting the top 25 collaborators of Iring Heisler. A scholar is included among the top collaborators of Iring Heisler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iring Heisler. Iring Heisler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nandekar, Prajwal P., et al.. (2024). Mechanistic insights into the selective targeting of P2X3 receptor by camlipixant antagonist. Journal of Biological Chemistry. 301(1). 108109–108109. 2 indexed citations
2.
Hahnel, Steffen, William M. Roberts, Iring Heisler, Daniel Kulke, & Janis C. Weeks. (2021). Comparison of electrophysiological and motility assays to study anthelmintic effects in Caenorhabditis elegans. International Journal for Parasitology Drugs and Drug Resistance. 16. 174–187. 8 indexed citations
3.
Friberg, Anders, Hartmut Rehwinkel, Duy Nguyen, et al.. (2020). Structural Evidence for Isoform-Selective Allosteric Inhibition of Lactate Dehydrogenase A. ACS Omega. 5(22). 13034–13041. 32 indexed citations
4.
Hahnel, Steffen, et al.. (2020). Caenorhabditis elegans in anthelmintic research – Old model, new perspectives. International Journal for Parasitology Drugs and Drug Resistance. 14. 237–248. 46 indexed citations
5.
Siebeneicher, Hölger, Marcus Bauser, Bernd Buchmann, et al.. (2016). Identification of novel GLUT inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(7). 1732–1737. 40 indexed citations
6.
Siebeneicher, Hölger, Arwed Cleve, Hartmut Rehwinkel, et al.. (2016). Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876. ChemMedChem. 11(20). 2261–2271. 212 indexed citations
7.
Kapoor, Khyati, Janet Finer-Moore, Bjørn Panyella Pedersen, et al.. (2016). Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides. Proceedings of the National Academy of Sciences. 113(17). 4711–4716. 167 indexed citations
8.
Kopitz, Charlotte, Luisella Toschi, Carolyn Algire, et al.. (2016). Abstract 4746: Pharmacological characterization of BAY-876, a novel highly selective inhibitor of glucose transporter (GLUT)-1 in vitro and in vivo. Cancer Research. 76(14_Supplement). 4746–4746. 7 indexed citations
9.
Golfier, Sven, Charlotte Kopitz, Antje Kahnert, et al.. (2014). Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect. Molecular Cancer Therapeutics. 13(6). 1537–1548. 191 indexed citations
10.
Ellinghaus, Peter, Iring Heisler, Kerstin Unterschemmann, et al.. (2013). BAY 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I. Cancer Medicine. 2(5). 611–624. 179 indexed citations
11.
Haerter, Michael, Peter Ellinghaus, Iring Heisler, et al.. (2011). Abstract 4509: BAY 87-2243 targets hypoxia-induced activation and stabilization of HIF-1α: A novel approach to overcome resistance mechanisms in cancer therapy. Cancer Research. 71(8_Supplement). 4509–4509. 2 indexed citations
12.
Golfier, Sven, Antje Kahnert, Iring Heisler, et al.. (2011). Abstract 1754: Identification of BAY 94-9343, a mesothelin antibody-drug conjugate (ADC): Characterization and anti-tumor activity in mesothelin-positive preclinical tumor models. Cancer Research. 71(8_Supplement). 1754–1754. 5 indexed citations
13.
Bachran, Christopher, et al.. (2008). Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cells. Cancer Biology & Therapy. 7(2). 237–242. 14 indexed citations
14.
Fuchs, Hendrik, Christopher Bachran, Tongyu Li, et al.. (2006). A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice. Journal of Controlled Release. 117(3). 342–350. 34 indexed citations
15.
Bachran, Christopher, et al.. (2006). The Saponin-Mediated Enhanced Uptake of Targeted Saporin-Based Drugs is Strongly Dependent on the Saponin Structure. Experimental Biology and Medicine. 231(4). 412–420. 47 indexed citations
16.
Heisler, Iring, et al.. (2005). Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cells. Journal of Controlled Release. 106(1-2). 123–137. 55 indexed citations
17.
Bachran, Christopher, Iring Heisler, Hendrik Fuchs, & Mark Sutherland. (2005). Influence of protein transduction domains on target-specific chimeric proteins. Biochemical and Biophysical Research Communications. 337(2). 602–609. 9 indexed citations
18.
Heisler, Iring, et al.. (2002). A Colorimetric Assay for the Quantitation of Free Adenine Applied to Determine the Enzymatic Activity of Ribosome-Inactivating Proteins. Analytical Biochemistry. 302(1). 114–122. 89 indexed citations
19.
Heisler, Iring, et al.. (2002). A cleavable adapter to reduce nonspecific cytotoxicity of recombinant immunotoxins. International Journal of Cancer. 103(2). 277–282. 40 indexed citations
20.
Heisler, Iring, et al.. (2001). Development of a novel molecular adapter for the optimization of immunotoxins. Journal of Controlled Release. 74(1-3). 259–261. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia R. Oliva Breakdown of academic impact, for papers by Jessica Hauschild Breakdown of academic impact, for papers by Feifei Xu Breakdown of academic impact, for papers by Melissa Millard Breakdown of academic impact, for papers by Danuta Duś Breakdown of academic impact, for papers by Craig D. Simpson Breakdown of academic impact, for papers by Helena Pópulo Breakdown of academic impact, for papers by Kazi Mokim Ahmed Breakdown of academic impact, for papers by Rama Rao Malla Breakdown of academic impact, for papers by Valeriy Filonenko
Rankless by CCL
2026